Assoc. Prof. Imo Hoefer, FESCDept of Experimental Cardiology, UMC Utrecht, G02.523,Heidelberglaan 1003584 CX Utrecht - The NetherlandsTel: +31 88 755 8654, Fax: +31 30 252 2693, email
Prof. Paul Evans University of Sheffield, Medical School,Beech Hill Road,Sheffield,Sheffield S10 2RX - United KingdomTel: +44 114 2712591, email
Prof. Christian Weber, FESCInstitute For Cardiovascular PreventionKlinikum LMU MuenchenPettenkoferstrasse 980336 Muenchen - GermanyTel: +49 8951604350, Fax: +49 8951604352, email
Prof. Sabine Steffens, FESCInstitute of Cardiovascular PreventionPettenkoferstrasse 8a80336 Munich - GermanyTel : +49-(0)89-5160-4674 - E-mail
Dr. Giuseppina Caligiuri, FESC (FR), emailDr. Marie-Luce Bochaton-Piallat (CH), emailAssoc. Prof. Jose Tuñón-Fernandez, FESC (ES), email Assist. Prof. Daniel Ketelhuth (SE), emailProf. Esther Lutgens (NL),emailDr. Christian Matter (CH), emailDr. Andrea Caporali (UK), email
Dr. Claudia Monaco, FESC (UK), emailSecretary & TreasurerProf. Andreas Schober (DE), emailConnect with the editorial boards of various cardiovascular journalsProf. Paul Holvoet, FESC (BE), emailConnect the nucleus with the editors of the working group’s textbook.
The name of the Working Group of Pathogenesis of Atherosclerosis has been changed to ‘Atherosclerosis and Vascular Biology’.
The nucleus has had three meetings discussing this topic in depth and has taken a vote on this during the nucleus meeting in Munich (September 2008) where every nucleus member approved and strongly supported this change.
The main reason for this request is that we would like to embrace a large number of scientists in Europe working in the field of atherosclerosis , genetics and vascular biology. The current name restricts the interest of scientists .The working group has been campaigning very hard to increase the number of members under the leadership of Gerard Pasterkamp and last year we had a stand during the European Atherosclerosis Society Congress where we were able to interact with scientists working in the field. There we found out that the main reason for their lack of interest was the name of the group, some thought it was for pathologists only.
The Atherosclerosis field has undergone large changes In the last decade. While it was a lipid driven field around 1990, it changed completely by the introduction of genomics and the availability of knock out animals. This approach has broadened the field and focus has shifted towards finding vascular pathways leading to progression of atherosclerosis. In addition, several treatment modalities are being developed by this group. As a consequence societies have changed their name to include this effort. There is a large group of scientists we can interest in the ESC with the change of the working group name.We have considered this very carefully and found that none of the other working groups of the ESC are covering this field.
We have a very motivated and dynamic working group and hope that we can embrace a large group of scientists.
Lale Tokgozoglu MD,FACC,FESC Chairperson of the Working Group on Atherosclerosis and Vascular Biology (2008-2010
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved